AMSIDINE

This brand name is authorized in Estonia, Ireland, Netherlands, United Kingdom

Active ingredients

The drug AMSIDINE contains one active pharmaceutical ingredient (API):

1 Acridinyl Anisidide UNII 00DPD30SOY - AMSACRINE

Amsidine is a sterile antitumour chemotherapeutic agent for intravenous infusion. Although not completely clarified, the mode of action of amsacrine is related to its property of binding the DNA through intercalation and external (electrostatic) forces. Read about Acridinyl Anisidide

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
AMSIDINE 50mg/ml Concentrate and solvent for solution for infusion	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01XX01	Amsacrine	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01X Other antineoplastic agents → L01XX Other antineoplastic agents
Discover more medicines within L01XX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1880490
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 244039
Country: NL	Z-Index G-Standaard	Identifier(s): 13717782
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 135941